Conceptual copper and teal sculpture representing two blend components
Research

BPC-157 + TB-500 20 mg Blend: Lab Results Explained

LAB REPORT EXPLAINED

Conceptual copper and teal sculpture representing two blend components
AI-generated conceptual illustration of two components, not an accurate molecular structure. The actual certificate is displayed below.

Component-level testing makes a peptide blend easier to understand. This two-page report shows BPC-157 and TB-500 separately, giving readers a clear view of the measured balance and a complete certificate to explore.

Two components, two sets of results

ComponentLabel claimNet contentPurity
BPC-15710.00 mg10.23 mg99.61%
TB-50010.00 mg10.50 mg99.59%

For sample BLD-102, report COA-2026-SC-00977 gives a total net peptide content of 20.73 mg against a 20.00 mg claim. That is 103.7% of the total claim as rounded on the certificate. BPC-157 is reported at 102.3% of its individual claim and TB-500 at 105.0%.

The measured split is approximately 49.4% BPC-157 and 50.6% TB-500 by net peptide content. Those composition percentages describe the relative amounts in the blend. They are different from the separate purity percentages.

Purity and content answer different questions

Chromatographic purity describes the target peptide’s share of the integrated analytical signal under the reported method. Net peptide content is a quantity in milligrams. Neither field should be confused with the total powder mass. The certificate’s purity definition excludes excipients, counterions and residual water from what the percentage describes.

The reported total sample mass is 57.0 mg, not 57.0 mg of peptide. Nor does averaging the two purity results create an independently measured “blend purity” figure. Preserve each component result as the laboratory presents it.

Why the second page matters

The first page contains the sample information, QR code, quantities and purity table. The second page provides the LC-MS/MS details for each peptide and the report limitations. Reading both keeps the analytical context attached to the headline results.

This certificate concerns the combined 10 mg + 10 mg formulation. It should not be substituted for a certificate covering standalone BPC-157, standalone TB-500, or a blend with different component amounts.

BPC-157 10 mg + TB-500 10 mg: laboratory report

20.73 mg total net content: BPC-157 10.23 mg (99.61% purity) and TB-500 10.50 mg (99.59% purity).

Submitted sample BLD-102 · Report COA-2026-SC-00977 · PDF date August 14, 2026. These results apply to this submitted sample; match your product’s batch documentation before applying them to another vial.

Every page of the actual certificate is displayed below. Select a page to enlarge it, including its original QR code.

Original BPC-157 10 mg + TB-500 10 mg certificate, page 1 of 2, report COA-2026-SC-00977
Page 1 of 2 — complete, unaltered certificate page. Open full size ↗
Original BPC-157 10 mg + TB-500 10 mg certificate, page 2 of 2, report COA-2026-SC-00977
Page 2 of 2 — complete, unaltered certificate page. Open full size ↗

How to verify this report with the lab

  1. Scan the original QR code on page 1 with a phone camera. On the same phone, open the laboratory verification page instead.
  2. Enter PTC-47VY5LAE and select Verify. Check for the certificate confirmation and portal issue date August 15, 2026.
  3. Open the lab-hosted PDF. Match sample BLD-102, report COA-2026-SC-00977, PDF date August 14, 2026, formulation and analytical results to the pages shown here. The portal sample label is BLD-102_Blend_CoA_20260814_054743.

Date distinction: the PDF is dated August 14, 2026; the verification portal lists August 15, 2026. These are displayed separately because the portal does not explain the difference.

We checked the laboratory record and confirmed that its downloadable PDF exactly matches the supplied file. Compare the lab-hosted PDF ↗. This is document verification, not independent retesting. The report does not establish sterility, endotoxin levels, storage stability, clinical effectiveness or safety for human use, and does not validate dosing guidance.

Reading the evidence in context

A certificate is a record of a particular submitted sample. It does not establish that every vial or every later batch has the same composition. Compare the sample identification and formulation with the accompanying batch documentation, and retain the complete report rather than a cropped purity claim.

The reports describe LC-MS/MS analysis. They do not include a sterility result, an endotoxin result, a storage study or a clinical assessment. A confirmed verification code establishes that a document is in the issuing service’s records; it does not independently validate the analytical methods or retest the material.

For a fuller explanation of the fields, see how to read a peptide COA. Browse the research blog for more report reviews.

Leave a Reply

Your email address will not be published. Required fields are marked *